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Editorial on the Research Topic
Risk-Based Evidence for Animal Health Policy
Infectious animal and zoonotic diseases are important and immediate global disease threats
which exhaust resources and place demands on both national and international global animal
and human health institutions and infrastructures. These diseases create challenges for industry
stakeholders and policy-makers because of their pandemic potential and resultant widespread
economic and social disruption. The current pandemic of the coronavirus SARS-CoV-2 (disease
name COVID-19), which was first detected in the wet markets of Wuhan, Hubei Province, China,
offers a contemporary example on which we might reflect about the lessons learned from this
Research Topic—in particular, the importance of transparent data sharing and the development
of risk-based evidence for policy-making for zoonotic disease outbreak preparedness and control.
COVID-19 has now been detected in 188 international locations despite the closure of the wet
markets and imposition of movement restrictions and other interventions to reduce risks of
onward transmission. Risk management decisions in different countries [such as the imposition
and subsequent release of social distance policies (1) and the introduction of compulsory mask-
wearing (2)] are not purely (public health) science-based. The political, cultural, and societal
dimensions of the pandemic have highlighted sharply the need to “remedy. . . disciplinary silos” (3)
through holistic interdisciplinary approaches to understand the complex trade-offs and unintended
consequences of disease control policies.
In this Research Topic, we wanted to explore the development of a robust and fit-for-purpose
evidence base for animal (and public) health and the different mechanisms used to ensure its
effective delivery to policy-makers in order to better anticipate and respond appropriately to
existing and emerging animal and zoonotic disease risks. The response to the call for papers yielded
17 accepted papers with 112 contributing authors and the Research Topic has been accessed more
than 25,000 times highlighting the importance and timely nature of these contributions. In this
editorial, we identify 5 key lessons learned from these contributions and consider the future for
risk-based policy-making for animal and public health.
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IMPROVE UNDERSTANDING AND
COMMUNICATION OF CONCEPTS OF
RISK AND UNCERTAINTY TO DIFFERENT
STAKEHOLDER AUDIENCES
Policy and decision-making is not based on scientific evidence
alone, but also influenced by political will, existing governance
structures, public opinion, and other exogenous factors.
Researchers need to engage with all of these facets in a holistic
way, but this is challenging to do in the context of traditional
research environments. More reflects on these difficulties and
highlights the need for a commitment to integrate “policy
relevance to the research focus from the outset, to engage
with policy-makers and other stakeholders throughout, to use
platforms to facilitate science-policy dialogue, and to disseminate
research findings appropriately.” He articulates the need and
demand for interdisciplinary approaches—and in particular,
input from the social sciences, which stems from the recognition
that science, itself, is not value-free.
Assembling multi-disciplinary teams with appropriate
expertise is fundamental to delivering appropriate and effective
risk assessment, communication, and management. Countries
have varying approaches to prioritizing disease risks for
contingency planning which reflect the economic, social, and
cultural values of their communities. Two papers in this series
explore risk prioritization and perception, through different
disciplinary approaches. Bessell et al. use a semi-quantitative
approach which uses a combination of the rate of disease
spread, disease mitigation factors, impacts on animal welfare and
production, the human health risks and the impacts on wider
society to characterize exotic disease priorities for Scotland. In
contrast, Waldman et al., explore the role of the social, economic,
and cultural context in shaping the perceptions and practices of
actors who play significant roles in risk management. This paper
illustrates the importance of understanding “situated expertise”
and particular forms of risk perception and practice which
both enhance and compromise risk reduction in different ways”
(Waldman et al.).
ANTICIPATE REGULATORY OR POLICY
BARRIERS TO ENSURE EFFECTIVE
IMPLEMENTATION OF SCIENTIFIC
EVIDENCE
The foundations of evidence-based decision-making begin
with robust data collection, access and sharing. Houe et al.
acknowledge that although there may be a wealth of data
generated, many datasets have emerged from different
organizations and have been developed for other purposes,
making it difficult to integrate them and use them to their full
potential. Appropriate regulations and policies need to be in
place for data access and sharing across organizational and legal
boundaries. Sustaining the value of these datasets to researchers
and decision-makers depends almost entirely on data accuracy
and reliability; substantial changes in data architecture and
structure, which inevitably occur over time, need to be taken
into account to ensure that risk management decisions based on
these data are justified and valid. Continued investment into the
maintenance and “upkeep” of these data is therefore critical for
these data to be useful to policy-makers.
INTEGRATE DIFFERENT DATA SOURCES
TO IMPROVE DISEASE MONITORING AND
SURVEILLANCE
Estimating the risk of incursion of disease depends on
transparent data sharing, robust animal health recording systems
and fit-for-purpose veterinary public health infrastructure
which includes access to affordable diagnostic tests, laboratory
facilities, and trained technicians, veterinary professional,
paraprofessionals, and researchers to interpret and act on results.
Georgaki et al. describe the advantages of the Bluetongue
surveillance programme in Northern Ireland, which has evolved
to include the use of risk assessments and simulation models
to monitor the risk of incursion. Its design enables effective
mitigation measures to be identified to minimize disease risk
and provides additional assurances to protect NI’s export markets
in the European Union (EU) and third countries. The authors
also highlight the benefits of including both active and targeted
surveillance activities to enable early detection of disease.
In Scotland, risk-based approaches are also used to identify
high risk areas for vector-borne diseases, such as Louping ill
virus (See Gilbert et al.). GIS-based data on environmental
variables, when used in combination with sero-prevalence data,
become a powerful tool to identify risk factors and improve
opportunities for identification of alternative disease reservoirs.
Both of these are important for informing disease management
policies and identifying trade-offs between environmental and
farming priorities and costs. These insights are echoed in the
contributions by Carneiro et al. and Semango et al. which
remind us of the value of traditional field-based epidemiology
and recognize the importance of a systems-based approach. As
highlighted by the example of COVID-2019, a broad and holistic
understanding of the causal risk pathways is necessary to ensure
that critical disease reservoirs are also appropriately incorporated
into strategies for surveillance and risk mitigation.
INVEST IN PROACTIVE DEVELOPMENT OF
RISK ASSESSMENT EXPERTISE AND




The majority of the contributions in this Research Topic
identified the usefulness of investing in proactive veterinary risk
assessments which include risk pathways that can be flexibly
adapted and re-used in times of emergency to ensure business
continuity (see Auty et al.; de Vos et al.; Taylor et al.; Umber
et al.; Walz, Middleton et al.; Walz, Evanson et al.). For example,
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estimates of the risk of onward transmission of disease associated
with movements of carcasses from de-populated farms to other
areas for disposal inform risk management decisions about
movements of vehicles, animals and animal products out of
disease control areas (Umber et al.; Walz, Evanson et al.). While
there is a lot of guidance available for animal-related product
movements and for a variety of carcass types, there may be
country, disease or species-specific gaps which are necessary to
fill in order to “assist regulatory authorities in using risk” to guide
decision-making (for example to grant permitted movement
or deny a request to move for live animals or carcasses) (see
Umber et al.). Proactively working to elucidate these risks
coupled with efforts to identify and address data and research
gaps can help countries minimize the risk of disease spread
while also minimizing the impact of the outbreak response on
unaffected farms.
INCORPORATE SOCIAL SCIENCE AND




Risk assessment is essential to target critical control points
which are amenable to risk reduction. Although technical
solutions—such as improved diagnostic testing regimens and
disease control strategies—are available, their effectiveness
depends on the compliance and uptake of interventions by
key stakeholders. Two papers explored the likelihood of uptake
of technological interventions, using distinct approaches. Mohr
et al., used economic game theory as a framework to evaluate
farmers’ strategic decision-making in different contexts. The
work explores the uptake of an effective diagnostic test for
sheep-scab—a disease which costs more than £8 million
per year to the UK industry. In theory, the benefits of
control should outweigh the costs of the test. However, this
paper illustrates that the likelihood of uptake depends very
much on the farmer’s perception of risk to the herd and
whether they take a long- or short-term view of profitability.
Liu et al. explore this problem in a different way. The
authors construct different behavioral typologies of farmers
which they refer to as: “non-adopters,” “current adopters,” or
“future adopters” with respect to different technologies. Their
paper suggests that in order to be successful, we need to
better understand our stakeholder populations so that policies,
regulatory incentives, and complementary training can be
appropriately targeted to ensure effective uptake and positive
behavioral change.
A FORWARD LOOK: CREATE NEW
PATHWAYS TO IMPROVE
DECISION-MAKING
New technologies and methodologies in human and veterinary
medicine, epidemiology, agricultural production systems, and
business tools and approaches have the capacity to deliver
large volumes of high-quality data and complex analyses to
improve animal and zoonotic disease surveillance and outbreak
preparedness. However, scientific evidence is usually only a small
part of the evidence base for decision-makers. Incorporating
these advances into policy-making can be challenging, given the
silos that exist between human and animal health institutions,
differences between research, policy and industry timescales,
and the need to consider multiple evidence bases and different
stakeholder groups. Without established effective and explicit
communication channels between scientists, policy, and industry
audiences, researchers will struggle to respond to policy
needs with relevant research to inform decision-making in a
timely and robust manner. Models of science-policy delivery
through innovative, multi-disciplinary partnerships between
academia, industry, and government (such as the Scottish
Government Centers of Expertise, described by Boden et al.),
may offer a solution, particularly when combinedwith purposeful
communication and innovation aimed at these five lessons.
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